Lithethefatsi tsa Peptide li bontšitse bokhoni bo boholo lefapheng la tlhahlobo ea mafu le kalafo ka lebaka la ts'ebetso ea tsona e phahameng, chefo e tlase le boits'oaro bo phahameng. Leha ho le joalo, lithethefatsi tsa peptide le tsona li na le mefokolo e itseng, joalo ka li-peptide li senyeha habonolo ke li-enzyme ka har'a vivo, ho fella ka nako e khutšoanyane ea katleho le tlhokahalo ea tsamaiso khafetsa, 'me li-peptide tse ling li ka tsosa karabelo ea 'mele ea ho itšireletsa mafung, e amang katleho ea kalafo le litla-morao, 'me li-peptide ha li qhibilihe hantle metsing, e amang bioavailability ea hae. Ho hlola mathata ana, re atlehile ho hlahisa polyethylene glycol (PEG) phetoho ea ho ntlafatsa haholo thepa ea pharmacokinetic le ho eketsa botsitso ba lithethefatsi tsa peptide. thepa ea pharmacokinetic ea lithethefatsi tsa peptide, ho ntlafatsa botsitso le bioavailability ea bona.
Likhatelo-pele tsa Theknoloji
- Controlled modification: A variety of PEG derivatives and linker arms have been developed to precisely control the length, branching structure and linkage of PEG molecules to optimize the modification effect.
- Multi-functional modification: Combining PEG modification with other modification technologies (mohlala. fatty acid modification, glycosylation modification, etc.) to provide peptide drugs with more functionalities, such as targeting and slow release.
- Site-specific modification: Through chemical synthesis, PEG molecules are precisely attached to the specific sites of peptides to avoid affecting their active sites.
Melemo ea Setsebi
Prolonged half-life: PEG modification can increase the size of peptide molecules, reduce renal filtration, and protect peptides from enzymatic degradation, thus significantly prolonging their half-life.
Reduced immunogenicity: Ho pata li-epitopes tsa antigenic holim'a peptide ho fokotsa matla a eona a ho itšireletsa mafung le ho fokotsa litla-morao..
Solubility e ntlafalitsoeng: E ntlafalitse ka katleho ho solubility le bioavailability ea lithethefatsi tsa peptide.
Ntlafatso ya botsitso: Ho ntlafatsa ka katleho botsitso ba mocheso le lik'hemik'hale tsa lithethefatsi tsa peptide, le ho eketsa nako ea bona ea polokelo.
Libaka tsa Kopo
Theknoloji ea phetoho ea Peptide PEG e na le mefuta e mengata ea lits'ebetso mafapheng a mangata, joalo ka:
Tsoelo-pele ea lithethefatsi: E sebedisetswa ho hlahisa nako e telele, chefo e tlase, lithethefatsi tse lebisitsoeng tsa peptide, joalo ka li-peptide tse thibelang mofetše, li-peptide tsa antibacterial, li-peptide tsa analgesic, etc.
Li-reagents tsa ho hlahloba: bakeng sa nts'etsopele ea li-reagents tsa tlhahlobo ea peptide tse hlokolosi haholo, joalo ka li-reagents tsa ho lemoha tumor, li-reagents tsa ho lemoha kokoana-hloko.
Lintho tse phelang: E sebelisoa ho hlahisa li-biomaterials tsa peptide tse lumellanang le tse sebetsang, joalo ka li-scaffolds tsa boenjiniere ba li-tissue le litsamaiso tsa phepelo ea lithethefatsi.
